We found that there is a striking correlation between the strength of the HOXC4 or HOXC6 binding sites and the strength of the binding sites for the key prostate cancer transcription factors HOXB13, FOXA1, and AR (Fig 5A). This evidence concerns the gene HOXC4 and prostate carcinoma.